Randomized Trial Comparing the Effect of Endometrial Shedding With Medroxyprogesterone Acetate With Random Start of Clomiphene Citrate for Ovulation Induction in Oligo-ovulatory and Anovulatory Women

被引:1
|
作者
Jones, Claire Ann [1 ,2 ]
Garbedian, Kimberly [3 ]
Dixon, Marjorie [2 ,4 ]
Murphy, Kellie [2 ,5 ]
Shapiro, Heather [1 ,2 ]
机构
[1] Mt Sinai Hosp, Ctr Fertil & Reprod Hlth, Dept Obstet & Gynaecol, Toronto, ON, Canada
[2] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada
[3] Hannam Fertil Ctr, Toronto, ON, Canada
[4] First Steps Fertil Clin, Toronto, ON, Canada
[5] Mt Sinai Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada
关键词
Polycystic ovary syndrome; medroxyprogesterone acetate; clomiphene; ovulation induction; infertility;
D O I
10.1016/j.jogc.2016.01.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: A recent retrospective study demonstrated that anovulatory infertile women who did not have a progestogen-induced withdrawal bleed before treatment with clomiphene citrate (CC) had higher pregnancy rates than women who had a withdrawal bleed and those who had spontaneous menstrual bleeding. We sought to assess endometrial thickness at the time of ovulation in oligo-ovulatory and anovulatory women who took CC with or without a preceding progestogen-induced withdrawal bleed. Methods: We conducted a pilot randomized trial in which women with infertility and oligomenorrhea or amenorrhea were randomly assigned to take either CC after a withdrawal bleed induced by medroxyprogesterone acetate (MPA) 10 mg daily for 10 days or to take CC without such a bleed. Study participants underwent cycle monitoring with ultrasound assessment of endometrial thickness at the time of LH surge or a human chorionic gonadotropin trigger, followed by timed intercourse or intrauterine insemination. Women who had not ovulated by cycle day 21 took an increased dose of CC, with or without an MPA-induced withdrawal bleed, to a maximum of three cycles. Participants and nurses were asked to complete a questionnaire about the study. Results: There was no significant difference in endometrial thickness on the day of LH surge or human chorionic gonadotropin trigger between women who had a progestogen-induced withdrawal bleed and those who did not (P = 0.65). On average, the time to ovulation was 15 days longer in women who took MPA than in women who did not, but this difference was not statistically significant (P = 0.65). Satisfaction with the study was reported as high by both patients and nurses. Conclusion: In anovulatory or oligo-ovulatory women treated with CC, we found no significant difference in endometrial thickness whether or not the use of CC was preceded by a withdrawal bleed induced by MPA.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 45 条
  • [1] A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction
    Boostanfar, R
    Jain, JK
    Mishell, DR
    Paulson, RJ
    [J]. FERTILITY AND STERILITY, 2001, 75 (05) : 1024 - 1026
  • [2] Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial
    Chera-aree, Pattraporn
    Tanpong, Sirikul
    Thanaboonyawat, Isarin
    Laokirkkiat, Pitak
    [J]. BMC WOMENS HEALTH, 2023, 23 (01)
  • [3] Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial
    Pattraporn Chera-aree
    Sirikul Tanpong
    Isarin Thanaboonyawat
    Pitak Laokirkkiat
    [J]. BMC Women's Health, 23
  • [4] Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: A randomized controlled trial
    Bansal, Shavina
    Goyal, Manu
    Sharma, Charu
    Shekhar, Shashank
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 152 (03) : 345 - 350
  • [5] A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotropins
    Sipe, Christopher S.
    Davis, William A.
    Maifeld, Michelle
    Van Voorhis, Bradley J.
    [J]. FERTILITY AND STERILITY, 2006, 86 (06) : 1676 - 1681
  • [6] Comparing the effect of clomiphene citrate and letrozole on ovulation induction in infertile women with polycystic ovary syndrome
    Najafi, Parisa Zarif
    Noghabi, Saeid Pasban
    Afzali, Narges
    Mohammadzadeh, Sanaz
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (02) : 268 - 271
  • [7] A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL TO EVALUATE A CLOMIPHENE STAIR STEP PROTOCOL VS STANDARD CLOMIPHENE (SSTEPS) FOR OVULATION INDUCTION IN ANOVULATORY WOMEN
    Neuhausser, W. M.
    Klein, J. U.
    Sauer, M. V.
    Lobo, R. A.
    Zimmermann, R. C.
    [J]. FERTILITY AND STERILITY, 2011, 96 (03) : S29 - S29
  • [8] Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis
    Gadalla, M. A.
    Huang, S.
    Wang, R.
    Norman, R. J.
    Abdullah, S. A.
    El Saman, A. M.
    Ismail, A. M.
    van Wely, M.
    Mol, B. W. J.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (01) : 64 - 76
  • [9] Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial
    Liu, Chang
    Feng, Guimei
    Huang, Wei
    Wang, Qiuyi
    Yang, Shiyuan
    Tan, Jing
    Fu, Jing
    Liu, Dong
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (11) : 872 - 876
  • [10] Tamoxifen Versus Clomiphene Citrate for Ovulation Induction in Women with Polycystic Ovary Syndrome A Prospective Randomized Trial
    Topcu, Hasan Onur
    Batioglu, Ali Sertac
    Islimye, Mine
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2017, 62 (9-10) : 507 - 512